Sivik Global Healthcare’s Alexion Pharmaceuticals ALXN Stock Holding History

Sivik Global Healthcare’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-45,000	Closed	-$6.08M	–	71
2019 Q1	$6.08M	Buy	+45,000	New	+$5.6M	2.24%	14
2018 Q4	–	Sell	-25,000	Closed	-$3.48M	–	62
2018 Q3	$3.48M	Sell	25,000 -5,000	-17%	-$627K	1.24%	37
2018 Q2	$3.73M	Hold	30,000	–	–	1.43%	36
2018 Q1	$3.34M	Sell	30,000 -10,000	-25%	-$1.2M	1.56%	28
2017 Q4	$4.78M	Sell	40,000 -20,000	-33%	-$2.44M	1.78%	23
2017 Q3	$8.42M	Sell	60,000 -50,000	-45%	-$6.79M	2.86%	6
2017 Q2	$13.4M	Buy	110,000 +60,000	+120%	+$6.98M	4.9%	1
2017 Q1	$6.06M	Sell	50,000 -10,000	-17%	-$1.29M	2.82%	9
2016 Q4	$7.34M	Hold	60,000	–	–	3.5%	6
2016 Q3	$7.35M	Buy	60,000 +30,000	+100%	+$3.86M	3.71%	7
2016 Q2	$3.5M	Sell	30,000 -20,000	-40%	-$2.84M	1.74%	28
2016 Q1	$6.96M	Buy	50,000 +20,000	+67%	+$2.94M	3.08%	6
2015 Q4	$5.72M	Buy	30,000 +5,000	+20%	+$873K	2.72%	8
2015 Q3	$3.91M	Hold	25,000	–	–	1.9%	22
2015 Q2	$4.52M	Buy	25,000 +5,000	+25%	+$863K	1.57%	25
2015 Q1	$3.47M	Buy	20,000 +200	+1%	+$36.2K	1.18%	37
2014 Q4	$3.66M	Sell	19,800 -5,200	-21%	-$964K	1.48%	29
2014 Q3	$4.15M	Buy	25,000 +10,000	+67%	+$1.64M	1.88%	19
2014 Q2	$2.34M	Buy	+15,000	New	+$2.37M	1.18%	39

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sivik Global Healthcare's ALXN Position: Q2 2019 in Review

Sivik Global Healthcare sold out of Alexion Pharmaceuticals (ALXN) in Q2 2019, closing a stake of 45,000 shares — an estimated $6.08M sold.

Sivik Global Healthcare first reported a position in ALXN in Q2 2014 and held it in 19 quarters. The position peaked at $13.4M in Q2 2017. 636 funds tracked by Wall St. Rank hold ALXN as of Q2 2019.

Sivik Global Healthcare reported no remaining Alexion Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Sivik Global Healthcare sold 45,000 Alexion Pharmaceuticals shares in Q2 2019, an estimated $6.08M.
Sivik Global Healthcare first reported a position in Alexion Pharmaceuticals in Q2 2014 and held it in 19 quarters.
Sivik Global Healthcare's Alexion Pharmaceuticals position peaked at $13.4M in Q2 2017.
636 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2019.

Based on Sivik Global Healthcare's 13F filing for Q2 2019, filed 14 Aug 2019.